Abdulla et al., 2023 - Google Patents
Isolation and diagnosis of biofilms of Klebsiella Pneumoniae bacteria and Candida Albicans yeast, and studying the sensitivity of the pathogens to antibiotics and …Abdulla et al., 2023
View PDF- Document ID
- 404816612712690634
- Author
- Abdulla S
- Dheeb B
- AL-Qaysi S
- Farhan M
- Massadeh M
- Hamid A
- Publication year
- Publication venue
- Egyptian Academic Journal of Biological Sciences, G. Microbiology
External Links
Snippet
Section describes the details of a laboratory study that was conducted between September 2022 and February 2023. The study was carried out at the laboratories of the Department of Life Sciences, College of Science, University of Baghdad, and the University of Al-Nahrain …
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | The impact of biofilm formation on the persistence of candidemia | |
| Razzaghi-Abyaneh et al. | Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran | |
| Hussein et al. | Studying the candida resistance and sensitivity for some antifungals | |
| Abdulla et al. | Isolation and diagnosis of biofilms of Klebsiella Pneumoniae bacteria and Candida Albicans yeast, and studying the sensitivity of the pathogens to antibiotics and antifungals | |
| Alrubayae et al. | Determination of genetic relationships and pathogenicity of oral candidiasis etiological agents in pediatric malignant patients in Basrah province, Iraq | |
| Dheeb et al. | Extraction of Klebsiella pneumoniae and Candida albicans Biofilm and Studying their Cytotoxic Effects on Human Lymphocytes. | |
| Nelson et al. | Identification and susceptibility profile of vaginal Candida species to antifungal agents among pregnant women attending the antenatal clinic of Thika District Hospital, Kenya | |
| Mehta et al. | Wickerhamomyces anomalous: a rare cause of fungemia causing febrile neutropenia in acute lymphoblastic leukemia | |
| Muangkaew et al. | Unveiling lodderomyces elongisporus as an emerging yeast pathogen: a holistic approach to microbiological diagnostic strategies | |
| Izzeldien et al. | Impact of Commiphora myrrha on bacteria (Streptococcus mutans and Lactobacillus species) related to dental caries | |
| Obaid et al. | Pattern of Multi Drug Resistance with Biofilm Formation among Klebsiellapneumoniaisolated from Fecal Samples of Diarrheal Iraqi Patients | |
| Kouadio-Yapo et al. | Resistance of Candida albicans to antifungal drugs in Abidjan (Cote dIvoire) | |
| Chowdhury et al. | Clinico-mycological characteristics and outcomes of rare yeast infections | |
| Selvan et al. | Monitoring the spectrum of candidemia and its anti-fungal resistance in a tertiary care Centre–An emerging global alarm | |
| Prabhakaran et al. | Prevalence of Candidial Infections with their Antifungal Susceptibility Pattern in a Tertiary Care Hospital. | |
| El-Shabrawy et al. | Screening for anti-fungal resistance in Candida species using chromogenic agar dilution | |
| Awayid et al. | Immunization against multi drug resistance uropathogenic E. coli Isolate from urinary tract infection in pregnancy | |
| El-Sheekh et al. | Antimicrobial potential of ulvan against multidrug-resistant oral biofilm-forming bacteria | |
| Liao et al. | Exploring the diversity and pathogenicity of Talaromyces species isolated from clinical in Southern China | |
| Ibrahim et al. | Detection of Candida spp. in Diabetic Septic Foot in Khartoum State Diabetic Center | |
| Oke et al. | In vitro antifungal activities of some mushroom extracts against yeast isolates among women with vulvovaginal candidiasis in a teaching hospital: Antifungal actions of mushroom extracts on vulvovaginal candidiasis | |
| Ali et al. | Evaluation effectiveness of fluconazole and Mirabilis jalapa extract against some pathological fungi. | |
| Radhamanalan et al. | Exploring the potential of postbiotic Limosilactobacillus fermentum as a novel therapeutic agent for Candida albicans | |
| Aubaeed et al. | Molecular identification of some candida spp. isolated from intensive care unit patients and evaluation of their sensitivity to antifungals | |
| Razooqi et al. | Prevalence of forbidden contaminant clones of azoles and polyenes resistant Candida albicans in butter-cream ecosystem in Baghdad, Iraq. |